FDA Approves Expanded Access Program For Lipella Pharma's LP-310 In Oral Lichen Planus ...
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral ...
The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.
Rare Disease Patients Face Barriers in Access and Care
An FDA-approved medication can now treat Friedreich's ataxia, but health plan barriers and formulary exclusions keep many patients from receiving it.
Dr. Gupta details new FDA-approved pain medication with no opioids
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
JD Supra6 天
White House Introduces Cyber Trust Mark Program
The White House has introduced the Cyber Trust Mark program, a voluntary labeling initiative to help consumers easily identify secure Internet ...
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...